ARA 290 Pre Mixed Pen Peptide | 16mg – Advanced Support for Inflammation & Nerve Health

Description

What is ARA 290 Pre Mixed Pen Peptide | 16mg?

ARA 290 is a synthetic peptide inspired by the erythropoietin (EPO) hormone, but instead of promoting red blood cell production like traditional EPO, ARA 290 focuses on its anti-inflammatory and neuroprotective properties. This peptide has been researched for its potential benefits in managing neuropathic pain, improving cognitive function, and supporting overall kidney health. Unlike many other peptides, ARA 290 is designed to address systemic inflammation and support the body’s immune response.

Though still undergoing research, ARA 290 has shown promise in reducing chronic inflammation and supporting the healing of tissues, making it a valuable tool in various research fields, particularly those related to nerve health and inflammatory conditions.

Research Areas (In Vitro or Animal-Based Studies):

• Neuropathic Pain Relief: ARA 290 has been investigated for its ability to alleviate neuropathic pain, particularly in conditions like diabetic neuropathy and other nerve-related disorders.

• Cognitive Function Support: Research suggests ARA 290 could offer neuroprotective effects, especially for conditions such as Alzheimer’s disease and other neurodegenerative conditions.

• Kidney Health: Studies have shown that ARA 290 may help improve kidney function by reducing inflammation in chronic kidney conditions, making it a potential candidate for research on kidney disease management.

• Anti-Inflammatory Effects: The peptide has been studied for its role in controlling systemic inflammation, potentially supporting immune modulation and offering protection against chronic inflammatory conditions.

• Tissue Repair & Healing: ARA 290 demonstrates regenerative properties that could aid in cellular repair and enhance tissue healing.

• Lung Function: Research has shown potential benefits in lung health, particularly in conditions like sarcoidosis, by helping to regulate inflammation and improve overall lung function.

Scientific Studies & Clinical Trials:

ARA 290 has been involved in several clinical trials exploring its therapeutic potential:

• Diabetic Neuropathy Trial: A study with 204 participants showed significant pain relief and improved nerve function.

• Fibromyalgia Research: A clinical trial with 90 participants reported a reduction in pain and enhanced quality of life.

• Neuroprotection & Metabolism: A study involving 290 participants highlighted ARA 290’s ability to enhance glucose metabolism and protect neural pathways.

 

Example Tanning Cycle:
While ARA 290 is primarily used for research into neuropathic pain, cognitive function, kidney health, and inflammation, dosing cycles generally follow a 3-4mg per day regimen, lasting up to two months. Always follow specific research protocols for best results.

Dosage & Usage Instructions (For Research Use Only)

• Recommended Dosage: 3–4 mg/day (30–40 units)

• Administration Route: Subcutaneous injection

• Cycle Duration: Up to 8 weeks per research cycle

• Injection Notes:

  • Rotate sites to minimize irritation

  • Inject slowly and pause 10 seconds before withdrawing needle

 

Peptide Format

• Form: Pre-mixed Peptide Pen

• Concentration: 16mg per pen

• Units per Pen: 200 units (1 unit = 80mcg)

 

Potential Side Effects:

Though generally well-tolerated, side effects may include:

• Mild discomfort at the injection site.
• Temporary fluctuations in blood pressure or glucose levels.
• Rare cases of allergic reactions, including skin irritation or respiratory issues.

 

Storage Instructions:

• Store at 2°C to 8°C (refrigerated) to maintain potency.
• Keep away from direct sunlight and heat sources to preserve stability.

 

Why Choose ARA 290 from Peptide Amino?

At Peptide Amino, we offer high-purity, research-grade peptides sourced from trusted laboratories. Each batch is rigorously tested to ensure reliability and effectiveness for research purposes. Our temperature-controlled shipping ensures that your order arrives in perfect condition, ready for use in your research studies.

Disclaimer:

This product has not been evaluated by the Food and Drug Administration (FDA). It is not intended to diagnose, treat, cure, or prevent any disease. ARA 290 is for research purposes only and should only be handled by qualified professionals in a controlled research setting.